CLINICAL TRIALS PROFILE FOR ASCOMYCIN

Clinical Trials for Ascomycin

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00222183 ↗	Cutaneous Lupus Erythematosus and Elidel	Withdrawn	Novartis	N/A	This trial evaluates the therapeutic effect of Elidel (pimecrolimus) in comparison to the corresponding vehicle in patients with chronic discoid lupus erythematosus (dLE) or subacute cutaneous lupus erythematosus (scLE).
NCT00222183 ↗	Cutaneous Lupus Erythematosus and Elidel	Withdrawn	University of Leipzig	N/A	This trial evaluates the therapeutic effect of Elidel (pimecrolimus) in comparison to the corresponding vehicle in patients with chronic discoid lupus erythematosus (dLE) or subacute cutaneous lupus erythematosus (scLE).
NCT00231998 ↗	Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis	Completed	Novartis	Phase 3	Pimecrolimus, which is an ascomycin derivative, is an anti-inflammatory non-steroidal agent. In this study, the long-term safety and efficacy of Pimecrolimus cream will be evaluated in Japanese pediatric patients with atopic dermatitis. This study is a 6-month extension study following core study. THIS STUDY IS NOT ENROLLING PATIENTS IN THE UNITED STATES

Clinical Trial Conditions for Ascomycin

Condition Name

Condition Name
Intervention	Trials
Atopic Dermatitis	2
Lupus Erythematosus, Cutaneous	1
Lupus Erythematosus, Discoid	1

Condition MeSH

Condition MeSH
Intervention	Trials
Eczema	2
Dermatitis, Atopic	2
Dermatitis	2

Clinical Trial Locations for Ascomycin

Trials by Country

Trials by Country
Location	Trials
Japan	2
Germany	1

Clinical Trial Progress for Ascomycin

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 3	2
N/A	1

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	2
Withdrawn	1

Clinical Trial Sponsors for Ascomycin

Sponsor Name

Sponsor Name
Sponsor	Trials
Novartis	3
University of Leipzig	1

Sponsor Type

Sponsor Type
Sponsor	Trials
Industry	3
Other	1